Skip to main navigation Skip to search Skip to main content

Prospective Feasibility and Phase 1/2 Trial of Preoperative Proton Beam Therapy With Concurrent Chemotherapy for Resectable Stage IIIA or Superior Sulcus Non-Small Cell Lung Cancer

  • Charles B. Simone
  • , Nikhil Yegya-Raman
  • , Shwetha Manjunath
  • , Vivek Verma
  • , Jacob E. Shabason
  • , Lee Xu
  • , Keith A. Cengel
  • , William P. Levin
  • , Abigail T. Berman
  • , John P. Christodouleas
  • , Charu Aggarwal
  • , Roger B. Cohen
  • , Corey J. Langer
  • , Taine T. Pechet
  • , Sunil Singhal
  • , John C. Kucharczuk
  • , Ramesh Rengan
  • , Steven J. Feigenberg
  • University of Pennsylvania
  • New York Proton Center
  • Memorial Sloan-Kettering Cancer Center
  • University of Texas MD Anderson Cancer Center
  • University of Washington

Research output: Contribution to journal › Article › peer-review

1 Scopus citations
Original languageEnglish
Pages (from-to)683-689
Number of pages7
JournalInternational Journal of Radiation Oncology Biology Physics
Volume117
Issue number3
DOIs
StatePublished - Nov 1 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Antineoplastic Combined Chemotherapy Protocols/therapeutic use
  • Carcinoma, Non-Small-Cell Lung/radiotherapy
  • Combined Modality Therapy
  • Feasibility Studies
  • Humans
  • Lung Neoplasms/radiotherapy
  • Neoplasm Staging
  • Prospective Studies
  • Proton Therapy/adverse effects

Fingerprint

Dive into the research topics of 'Prospective Feasibility and Phase 1/2 Trial of Preoperative Proton Beam Therapy With Concurrent Chemotherapy for Resectable Stage IIIA or Superior Sulcus Non-Small Cell Lung Cancer'. Together they form a unique fingerprint.

Cite this